Newborn hearing screening is a quick and non-invasive test that is typically performed within the first few days of a baby’s life to determine if they have any hearing loss. The screening is conducted using a combination of methods, including otoacoustic emissions (OAE) and/or auditory brainstem response (ABR) testing.

OAE testing measures sound waves that are generated by the inner ear in response to sound, while ABR testing measures the brain’s response to sound. Both tests are painless and can be completed while the baby is asleep. The goal of newborn hearing screening is to identify any hearing loss as early as possible so that the baby can receive appropriate intervention and support.

The American Academy of Pediatrics recommends that all babies have a hearing screening before one month of age, and if necessary, a follow-up screening by three months of age. Early detection of hearing loss is essential because it can lead to better language development, improved social and emotional outcomes, and better academic performance.

If a baby does not pass the initial hearing screening, a follow-up test will be conducted to confirm the results. If hearing loss is confirmed, the baby will be referred to an audiologist for a comprehensive evaluation and appropriate intervention. Early intervention may include the use of hearing aids or cochlear implants, speech and language therapy, and other support services.

Newborn hearing screening is a quick and non-invasive test that is performed to identify any hearing loss in babies. The test is typically performed within the first few days of a baby’s life, and early detection of hearing loss is essential for better language development, improved social and emotional outcomes, and better academic performance. If hearing loss is identified, the baby can receive appropriate intervention and support to improve their hearing and overall quality of life.